GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CSLLY) » Definitions » Inventories, Other

CSL (CSLLY) Inventories, Other : $5,566 Mil (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is CSL Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. CSL's other inventories for the quarter that ended in Dec. 2023 was $5,566 Mil.

CSL's quarterly other inventories declined from Dec. 2022 ($5,057 Mil) to Jun. 2023 ($0 Mil) but then increased from Jun. 2023 ($0 Mil) to Dec. 2023 ($5,566 Mil).

CSL Inventories, Other Historical Data

The historical data trend for CSL's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Inventories, Other Chart

CSL Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CSL Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,806.60 - 5,057.30 - 5,566.00

CSL Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

CSL (CSLLY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CSLLY) » Definitions » Inventories, Other
Comparable Companies
ASX:TLX ASX:NEU ASX:IMU ASX:CU6 ASX:CUV ASX:MSB ASX:OPT ASX:IMM ASX:BOT ASX:PYC OCSE:NOVO B VRTX REGN XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB
Traded in Other Exchanges
CMXHF:USA CSJ:Germany CSL:Australia
Address
655 Elizabeth Street, Melbourne, VIC, AUS, 3000
Website
https://www.csl.com
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.